SH – On Target Laboratories Related Content
Cancer immunotherapy: Are we ready to take the next big step?
Sumith A Kularatne of On Target Laboratories, LLC highlights cancer immunotherapy as the treatment of the year to target cancer cells
Treatments for prostate cancer: Pros and cons
Dr Sumith A Kularatne, vice-president of R&D at On Target Laboratories, explores the pros and cons of various existing treatments for prostate cancer
Prostate cancer (PCa) is the second leading cause of cancer-related deaths in men, with about 1.1 million new cases and approximately 307,000 fatalities per year globally. This...
